All Stories

  1. Maternal mean arterial pressure and serum inhibin A as early predictors of hypertensive disorders in low‐risk pregnant women attending a University Teaching Hospital in Lagos, Nigeria: A prospective cohort study
  2. A randomized controlled trial of N-acetylcysteine in the treatment of early-onset preeclampsia: Study Protocol
  3. Gaps in Knowledge and Practice of Cervical Cancer Screening among Primary Health Care Workers in Lagos State, Nigeria: A Cross-Sectional Study
  4. A Randomized Controlled Trial of N-Acetylcysteine in the Treatment of Early-Onset Preeclampsia: Study Protocol
  5. Cancer: A looming public health crisis in Africa–a call to accelerate equitable access to medicines
  6. Randomized Controlled Trial of Impact of Mobile Health Technologies on Human Papillomavirus Vaccination Uptake in Mothers of Vaccine-Eligible Girls in Lagos, Nigeria (mHealth-HPVac)
  7. Topical 5-Fluorouracil and Imiquimod for the Treatment of High-Grade Cervical Intraepithelial Neoplasia: Protocol for a Randomised Open-Label Controlled Trial (TOPFIT-CIN Study)
  8. Impact of Genital Chlamydia Trachomatis Infection in Women Presenting with Infertility in Lagos, Nigeria
  9. Survival Outcomes Following Interval Versus Primary Debulking Surgery in Advanced Epithelial Ovarian Cancer: A Retrospective Cohort Study in Lagos, Southwest Nigeria
  10. Development of antepartum risk prediction model for postpartum hemorrhage in Lagos, Nigeria: A prospective cohort study (Predict‐PPH study)
  11. Prognostic performance of pretreatment systemic immune-inflammation index in women with epithelial ovarian cancer
  12. Serum Calcium and Magnesium Levels in Women with Uterine Fibroids in Southwest Nigeria: a Cross-sectional Study
  13. Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)–Study protocol
  14. Cervical Epithelial Abnormalities and Associated Factors among HIV-Infected Women in Lagos, Nigeria: A Cytology-Based Study
  15. Maternal tumour necrosis factor-alpha levels in preeclamptic pregnancies in Lagos, South-West Nigeria
  16. Prevalence and Risk Factors of Genital Human Papillomavirus Infections among Women in Lagos, Nigeria
  17. Comparative Assessment of p16/Ki-67 Dual Staining Technology for Cervical Cancer Screening in Women Living with HIV (COMPASS-DUST) – Study Protocol
  18. The use of and need for data and information by health professionals supporting the delivery of palliative cancer care services in sub-Saharan Africa: A qualitative study
  19. An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation
  20. Predictors of early mortality risk in patients with epithelial ovarian cancer
  21. Analysis of serum placental growth factor levels in preeclamptic and normotensive pregnant women in Lagos, Nigeria: a worthwhile screening tool?
  22. Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial
  23. Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria
  24. Acceptability and Potential Effectiveness of eHealth Tools for Training Primary Health Workers From Nigeria at Scale: Mixed Methods, Uncontrolled Before-and-After Study
  25. The effect of dehydroepiandrosterone (DHEA) supplementation on estradiol levels in women: A dose-response and meta-analysis of randomized clinical trials
  26. Impact of COVID-19 on utilization of maternal, newborn and child health services in Nigeria: protocol for a country-level mixed-methods study
  27. Data and information needs of policymakers for palliative cancer care: a multi-country qualitative study
  28. Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria
  29. Barriers and Facilitators of Access to Maternal, Newborn and Child Health Services During the First Wave of COVID-19 Pandemic in Nigeria: Findings From a Qualitative Study
  30. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
  31. Timing of surgery following SARS-CoV-2 infection
  32. Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria
  33. Effects of selenium supplementation on pregnancy outcomes and disease progression in HIV‐infected pregnant women in Lagos: A randomized controlled trial
  34. Stakeholder perspectives and requirements to guide the development of digital technology for palliative cancer services: a multi-country, cross-sectional, qualitative study in Nigeria, Uganda and Zimbabwe
  35. Awareness and practice of cord blood donation by pregnant women in Lagos Nigeria: Practice implication for future cord blood transplantation in Nigeria
  36. Volunteering during the COVID-19 pandemic: Attitudes and perceptions of clinical medical and dental students in Lagos, Nigeria
  37. e-Learning about pain and its management
  38. Effects of the Dietary Approaches to Stop Hypertension (DASH) on Pregnancy/Neonatal Outcomes and Maternal Glycemic Control: A Systematic Review and Meta-analysis of Randomized Clinical Trials
  39. Impact of COVID-19 on utilization of maternal, newborn and child health services in Nigeria: protocol for a country-level mixed-methods study
  40. Acceptability and Potential Effectiveness of eHealth Tools for Training Primary Health Workers From Nigeria at Scale: Mixed Methods, Uncontrolled Before-and-After Study (Preprint)
  41. Serum vitamin D deficiency and risk of epithelial ovarian cancer in Lagos, Nigeria
  42. Good clinical practice advice for the management of patients with gynaecological cancer during the COVID-19 pandemic in Nigeria and other resource-constrained countries
  43. Good clinical practice advice for the management of pregnant women with suspected or confirmed COVID‐19 in Nigeria
  44. The Influence of Fasting and Energy Restricting Diets on Blood Pressure in Humans: A Systematic Review and Meta-Analysis
  45. Impact of mobile technologies on cervical cancer screening practices in Lagos, Nigeria (mHealth-Cervix): Protocol for a randomised controlled trial
  46. Upheaval in cancer care during the COVID-19 outbreak
  47. Oral etoposide for treatment and/or maintenance treatment of recurrent epithelial ovarian cancer
  48. Prevalence and foetomaternal effects of iron deficiency anaemia among pregnant women in Lagos, Nigeria
  49. Prevalence of Rhesus C and D Alloantibodies among Rhesus-Negative Women of Child Bearing Age at a Tertiary Hospital in South-West Nigeria
  50. Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria
  51. Prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer
  52. Caesarean delivery of first prediagnosed COVID-19 pregnancy in Nigeria
  53. Association between maternal serum homocysteine concentrations in early pregnancy and adverse pregnancy outcomes
  54. Human papillomavirus and cervical cancer
  55. Review of immunohistochemical typing of endometrial carcinoma at the Lagos University Teaching Hospital
  56. Clinical experiences with the use of oxytocin injection by healthcare providers in a southwestern state of Nigeria: A cross-sectional study
  57. Understanding data and information needs for palliative cancer care to inform digital health intervention development in Nigeria, Uganda and Zimbabwe: protocol for a multicountry qualitative study
  58. Human papillomavirus and cervical cancer
  59. Primary vaginal adenocarcinoma of intestinal-type: case report of a rare gynaecological tumour
  60. Human Papillomavirus and Cervical Cancer
  61. Effects of selenium supplementation on pregnancy outcome and disease progression in HIV-infected pregnant women in Lagos, Nigeria
  62. Maternal serum vitamin D levels and preterm delivery among low‐risk parturients in Lagos, Nigeria
  63. Clinical experiences with the use of oxytocin injection by healthcare providers in a South-Western State Nigeria: A Cross sectional study
  64. Determinants of Uptake of Breast and Cervical Cancer Screening by Users in Lagos, Southwestern Nigeria
  65. Impact of using eHealth tools to extend health services to rural areas of Nigeria: protocol for a mixed-method, non-randomised cluster trial
  66. The pattern of comorbidities in cancer patients in Lagos, South-Western Nigeria
  67. Selenium deficiency and pregnancy outcome in pregnant women with HIV in Lagos, Nigeria
  68. Association between serum CA125 levels in preeclampsia and its severity among women in Lagos, South-West Nigeria
  69. Advanced Abdominal Pregnancy with Favorable Fetomaternal Outcome in Lagos, Nigeria
  70. Women's knowledge of cervical cancer and uptake of Pap smear testing and the factors influencing it in a Nigerian tertiary hospital
  71. Comparative analysis of serum trace element levels in women with invasive cervical cancer in Lagos, Nigeria
  72. The prevalence and risk factors for Trichomonas vaginalis infection amongst human immunodeficiency virus-infected pregnant women attending the antenatal clinics of a university teaching hospital in Lagos, South-Western, Nigeria
  73. A 4-Year Clinical Review of Elective Hysterectomies at a University Teaching Hospital in Lagos, Nigeria
  74. Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the out-patient clinics of a university teaching hospital in Lagos, Nigeria
  75. Knowledge, perceptions and practice of cervical cancer prevention among female public secondary school teachers in Mushin local government area of Lagos State, Nigeria
  76. Knowledge and Acceptability of Human Papillomavirus Vaccination among Women Attending the Gynaecological Outpatient Clinics of a University Teaching Hospital in Lagos, Nigeria
  77. A giant hydronephrotic pelvic kidney mimicking an ovarian cyst in a 34-week pregnancy
  78. Utilization of Cancer Information System for Breast Cancer Control in Lagos, Nigeria
  79. A 3-year review of the pattern of contraceptive use among women attending the family planning clinic of a University Teaching Hospital in Lagos, Nigeria
  80. A five year review of ovarian cancer at a tertiary institution in Lagos, South-West, Nigeria
  81. A successfully managed spontaneous heterotopic pregnancy diagnosed in the second trimester of pregnancy
  82. Hypercholesterolaemia in pregnancy as a predictor of adverse pregnancy outcome
  83. Seroprevalence of hepatitis B virus infection among pregnant women at the antenatal booking clinic of a Tertiary Hospital in Lagos Nigeria
  84. Anaemia among pregnant women at the booking clinic of a teaching hospital in south-western Nigeria
  85. Risk Factors for Pre-eclampsia in Multiparous Women in Lagos, Nigeria
  86. Preterm delivery and low maternal serum cholesterol level: Any correlation?
  87. Perinatal outcome in anaemic pregnant women in South-Western Nigeria
  88. A Study on the Association between Low Maternal Serum Magnesium Level and Preterm Labour
  89. Chlamydia trachomatis among women with normal and abnormal cervical smears in Lagos, Nigeria
  90. Oncogenic human papilloma virus infection among women attending the cytology clinic of a tertiary hospital in Lagos, South-West Nigeria
  91. Preterm delivery and low maternal serum cholesterol level: any correlation?
  92. Knowledge of, Perception of, and Attitude towards Uterine Fibroids among Women with Fibroids in Lagos, Nigeria